Skip to main content

Table 4 Vancomycin parameter estimates from the population PK model

From: Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis

Parameter

Typical Value (%RSEa)

Inter-individual Variability

%CV (%RSEa)

CL (L/h/80 ml/min), θCL

3.12 (6.1)

47.5 (13.2)

V1 (L/70 kg), θV1

43.5 (22.8)

92.2 (40.4)

Q (L/h), θQ

8.66 (51.6)

NE

V2 (L/70 kg), θV2

45.8 (19.1)

81.5 (30.1)

Residual Error Parameter

  

σ2 1prop (%)

23.2 (15.6)

  1. CLclearance, V 1 central volume of distribution, Q inter-compartmental clearance, V 2 peripheral volume of distribution, σ 2 1prop proportional component of the residual error model, NE not estimated
  2. a%RSE: percent relative standard error of the estimate = SE/parameter estimate * 100 (for variability terms this is the %RSE of the variance estimate)